Hims & Hers Health, Inc.
For the period ended Jun 30, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(c) Insider trading arrangements.
During the fiscal quarter ended June 30, 2026, none of our directors or officers adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, except as described in the table below:
| Name and Title of Insider | Adoption, Modification or Termination | Applicable Date | Duration of Trading Arrangement | Rule 10b5-1 Trading Arrangement?(Y / N) (1) | Aggregate Number of Securities Subject to the Trading Arrangement |
|---|---|---|---|---|---|
| Deborah Autor, Director and Chief Policy Officer | Termination | 5/20/2026 | 12/15/2025 - 12/21/2026 | Y | 14,109 |
| Deborah Autor, Director and Chief Policy Officer | Adoption | 5/20/2026 | 8/18/2026 - 5/18/2028 | Y | 277,466 |
| Oluyemi Okupe, Chief Financial Officer | Adoption | 5/20/2026 | 9/1/2026 - 9/1/2027 | Y | 819,730 |
| Soleil Boughton, Chief Legal Officer | Termination | 5/21/2026 | 2/27/2026 - 2/5/2027 | Y | 645,000 |
| Soleil Boughton, Chief Legal Officer | Adoption | 5/21/2026 | 8/19/2026 - 6/1/2027 | Y | 723,206 |
(1)Denotes whether the trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) when adopted.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.